FDA Approved: FEBUXOSTAT — Supplemental Application (Tris Pharma Inc)

View source ↗

Summary

The FDA approved a supplemental application for febuxostat from Tris Pharma Inc, enabling a generic version of the gout medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

SUPPL AP for FEBUXOSTAT (FEBUXOSTAT)